[1]
Miller JW, Adamis AP, Shima DT, D’Amore PA, Moulton RS, O’Reilly MS, et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 1994; 145: 574-84.
[2]
Kim LA, D'Amore PA. A brief history of anti-VEGF for the treatment of ocular angiogenesis. Am J Pathol 2012; 181: 376-9.
[3]
Parodi MB, Iacono P, Da Pozzo S. Anti-VEGF and Retinal Dystrophies. Curr Drug Targets 2020. Online ahead of print
[http://dx.doi.org/10.2174/1389450121666200428103334]
[http://dx.doi.org/10.2174/1389450121666200428103334]
[4]
Vilela MA. Use Of Anti-Vegf Drugs In Retinal Vein Occlusions Curr Drug Targets 2020. Online ahead of print
[http://dx.doi.org/10.2174/1389450121666200428101343]
[http://dx.doi.org/10.2174/1389450121666200428101343]
[5]
Giannaccare G, Pellegrini M, Bovone C, et al. Anti-VEGF Treatment in Corneal Diseases Curr Drug Targets 2020. Online ahead of print
[http://dx.doi.org/10.2174/1389450121666200319111710]
[http://dx.doi.org/10.2174/1389450121666200319111710]
[6]
Sorrentino FS, Jurman G, De Nadai K, Campa C, Furlanello C, Parmeggiani F. Application of Artificial Intelligence in Targeting Retinal Diseases. Curr Drug Targets 2020. Online ahead of print
[http://dx.doi.org/10.2174/1389450121666200708120646]
[http://dx.doi.org/10.2174/1389450121666200708120646]
[7]
Claudio Campa. New Anti-Vegf Drugs In Ophthalmology. Curr Drug Targets 2020. Online ahead of print
[http://dx.doi.org/10.2174/1389450121666200428101738]
[http://dx.doi.org/10.2174/1389450121666200428101738]
Current Drug Targets
Title:Anti-Vegf Therapy for Ocular Diseases: Present and Future
Volume: 21 Issue: 12
Author(s): Claudio Campa and Maurizio Battaglia Parodi
Affiliation:
Export Options
About this article
Cite this article as:
Campa Claudio and Parodi Battaglia Maurizio , Anti-Vegf Therapy for Ocular Diseases: Present and Future, Current Drug Targets 2020; 21 (12) . https://dx.doi.org/10.2174/138945012112200727153907
DOI https://dx.doi.org/10.2174/138945012112200727153907 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
67
3
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anti-VEGF Treatment in Corneal Diseases
Current Drug Targets Identification of Novel Anti-inflammatory Agents from Ayurvedic Medicine for Prevention of Chronic Diseases: “Reverse Pharmacology” and “Bedside to Bench” Approach
Current Drug Targets Phytochemical Genistein in the Regulation of Vascular Function: New Insights
Current Medicinal Chemistry Towards Newer Molecular Targets for Chronic Diabetic Complications
Current Vascular Pharmacology Purinergic Signalling and Endothelium
Current Vascular Pharmacology CB-12181, a New Azasugar-Based Matrix Metalloproteinase/Tumor Necrosis Factor-α Converting Enzyme Inhibitor, Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis in Vitro and Retinal Neovascularization in Vivo
Current Neurovascular Research Why and how do Microbubbles Enhance the Effectiveness of Diagnostic and Therapeutic Interventions in Cerebrovascular Disease?
Current Pharmaceutical Design The Medical and Medico-legal Complications of Bulimia Nervosa : Treatments and Complications
Current Women`s Health Reviews Growth Factors in the Pathogenesis of Retinal Neurodegeneration in Diabetes Mellitus
Current Neuropharmacology Enhanced Antioxidant and Protective Activities on Retinal Ganglion Cells of Carotenoids-Overexpressing Transgenic Carrot
Current Drug Targets Development of Patents and Clinical Trials on Regenerative Therapy: Gene Therapy
Recent Patents on Regenerative Medicine Neuroimaging of Non-Accidental Injury
Current Pediatric Reviews Treatment of Chronic Peripheral Arterial Disease
Current Vascular Pharmacology Modern drug delivery systems for targeting the posterior segment of the eye
Current Pharmaceutical Design Use of Anti-VEGF Drugs in Retinal Vein Occlusions
Current Drug Targets Optical Imaging of Microvascular Morphology and Perfusion
Current Angiogenesis (Discontinued) The Neuropeptide Systems and their Potential Role in the Treatment of Mammalian Retinal Ischemia: A Developing Story
Current Neuropharmacology In Vivo Application and Tracking of Baculovirus
Current Gene Therapy Stem Cell Therapies for Intracerebral Hemorrhages
Current Drug Delivery Nitric Oxide-Derived Oxidants with a Focus on Peroxynitrite: Molecular Targets,Cellular Responses and Therapeutic Implications
Current Pharmaceutical Design